Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124621632 | 12462163 | 2 | F | 20160627 | 20160613 | 20160707 | EXP | US-TEVA-667277USA | TEVA | LUPAK O, BOURGI K. NAPROXEN INDUCED PHENYTOIN TOXICITY IN A YOUNG AND HEALTHY PATIENT. JOURNAL OF GENERAL INTERNAL MEDICINE. 2016; 31:2(1):S683 | 58.00 | YR | M | Y | 0.00000 | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124621632 | 12462163 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Unknown | Y | 74129 | ||||||||||
| 124621632 | 12462163 | 2 | I | PHENYTOIN. | PHENYTOIN | 1 | Unknown | Y | U | 0 | 200 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124621632 | 12462163 | 1 | Back pain |
| 124621632 | 12462163 | 2 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124621632 | 12462163 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124621632 | 12462163 | Dizziness | |
| 124621632 | 12462163 | Drug interaction | |
| 124621632 | 12462163 | Nystagmus | |
| 124621632 | 12462163 | Toxicity to various agents | |
| 124621632 | 12462163 | Vertigo | |
| 124621632 | 12462163 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |